Stocklytics Platform
BIAF
bioAffinity Technologies
BIAFW3
$0.40arrow_drop_down42.88%-$0.30
Penny Stock
BIAF
BIAFW3

$0.40

arrow_drop_down42.88%

Performance History

Chart placeholder
Key Stats
Open$0.64
Prev. Close$0.70
EPS-
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$0.00
PE Ratio-
LOWHIGH
Day Range0.40
0.78
52 Week Range0.05
2.90
Ratios
Revenue-
EPS-

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About bioAffinity Technologies (BIAFW)

bioAffinity Technologies, Inc. (BIAFW) is a cutting-edge biotechnology company that specializes in the development and commercialization of innovative diagnostic tests for the early detection of cancer. Founded in 2006, the company has quickly established itself as a leader in the field, with a strong track record of success and a promising pipeline of products under development.
One of bioAffinity's flagship products is its CyPath Lung assay, which is designed to detect lung cancer at an early stage when treatment options are more effective. The assay uses a unique and proprietary technology called the CyPath Lung System, which analyzes sputum samples for the presence of cancer cells. This non-invasive test has the potential to revolutionize lung cancer screening and save countless lives.
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NASDAQ
add bioAffinity Technologies to watchlist

Keep an eye on bioAffinity Technologies

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is bioAffinity Technologies's (BIAFW) price per share?

The current price per share for bioAffinity Technologies (BIAFW) is $0.4. The stock has seen a price change of -$0.3 recently, indicating a -42.88% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for bioAffinity Technologies (BIAFW)?

For bioAffinity Technologies (BIAFW), the 52-week high is $2.9, which is 625% from the current price. The 52-week low is $0.05, the current price is 684.31% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is bioAffinity Technologies (BIAFW) a growth stock?

bioAffinity Technologies (BIAFW) has shown an average price growth of -3.66% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying bioAffinity Technologies as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is bioAffinity Technologies (BIAFW) stock price performance year to date (YTD)?

As of the latest data, bioAffinity Technologies (BIAFW) has a year-to-date price change of 255.87%. Over the past month, the stock has experienced a price change of -55.56%. Over the last three months, the change has been -74.84%. Over the past six months, the figure is 17.65%.
help

Is bioAffinity Technologies (BIAFW) a profitable company?

bioAffinity Technologies (BIAFW) has a net income of -$7.94M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 31.26% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -87.08% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $791.62K. Operating income is noted at -$7.97M. Furthermore, the EBITDA is -$8.03M.
help

What is the market capitalization of bioAffinity Technologies (BIAFW)?

bioAffinity Technologies (BIAFW) has a market capitalization of $0. The average daily trading volume is 0.7, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level